Skip to main content
Alina Markova, MD, Dermatology, New York, NY

Alina Markova MD


Associate Attending, Clinical Director of Dermatology Service

Request Appointment
  • 530 East 74th StreetNew York, NY 10021

  • Book by Phone+1(231) 680-2491

Overview of  Dr. Markova

Dr. Alina Markova is a dermatologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from The Warren Alpert Medical School of Brown University and has been in practice 6 years. She is one of 48 doctors at Memorial Sloan Kettering Cancer Center who specialize in Dermatology. She has more than 70 publications and over 500 citings.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterResidency, Dermatology, 2013 - 2016
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2013
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2012, MD
  • Johns Hopkins University
    Johns Hopkins UniversityBA, Mathematics, 2004 - 2008

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2012 - 2016
  • Dermatology
    American Board of Dermatology Dermatology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Dermatological Emergencies: The Skin As A Sentinal 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Press Mentions

  • Q&A with Director of the NIH Dermatology Consultation Service
    Q&A with Director of the NIH Dermatology Consultation ServiceDecember 24th, 2024
  • Are Nail Salon UV Lamps a Skin Cancer Risk?
    Are Nail Salon UV Lamps a Skin Cancer Risk?April 30th, 2014
  • Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
    Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast CancerFebruary 13th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: